R.I. Lopez

1.7k citations
8 papers · 170 indexed · h-index 6
Topics
HER2/EGFR in Cancer Research (4 papers)Cancer Treatment and Pharmacology (3 papers)Monoclonal and Polyclonal Antibodies Research (2 papers)
Partner nations
SwitzerlandRussiaHungary

In The Last Decade

R.I. Lopez

7 papers receiving 165 citations

Peers

R.I. Lopez
Comparison fields: 5 of 44
  • Oncology 117
  • Cancer Research 52
  • Molecular Biology 40
  • Pulmonary and Respiratory Medicine 37
  • Ecology, Evolution, Behavior and Systematics 25
Replace George Sandusky with:
George Sandusky United States
Lian Dee Ler Singapore
S Parry New Zealand
Anaïs Boulai France
Lucia Mentuccia Italy
Ariadna García Spain
Katrin Madjar Germany
Franziska Gabler Germany
Olga Ponomarova Ukraine
Wen-Hui Chen China
R.I. Lopez relative to George Sandusky United States George Sandusky's profile →
Citations per field
00.5×8.3×
George Sandusky · 1×
Citations per year

Countries citing papers authored by R.I. Lopez

Since Specialization
Citations

This map shows the geographic impact of R.I. Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.I. Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.I. Lopez more than expected).

Fields of papers citing papers by R.I. Lopez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.I. Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.I. Lopez. The network helps show where R.I. Lopez may publish in the future.

Co-authorship network of co-authors of R.I. Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of R.I. Lopez. A scholar is included among the top collaborators of R.I. Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.I. Lopez. R.I. Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 10
2 92
3 0
4 7
5 1
6 24
7 5
8
[A zinc sulfate and usnic acid preparation used as post-surgical adjuvant therapy in genital lesions by Human Papillomavirus].
31

About R.I. Lopez

R.I. Lopez is a scholar working on Oncology, Speech and Hearing and Radiology, Nuclear Medicine and Imaging, having authored 8 papers that have together received 170 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (117 citations), Cancer Research (52 citations) and Ecology, Evolution, Behavior and Systematics (25 citations). R.I. Lopez has collaborated with scholars based in Switzerland, Russia and Hungary. Frequent co-authors include Cheng S. Quah, David Cameron, Juan Carlos Alcedo, Igor Bondarenko, Stanislas Hubeaux, Carlos Bais, Jean‐Luc Canon, David Miles, Seock‐Ah Im and Neelima Denduluri. Their work appears in journals such as Annals of Oncology, European Journal of Cancer and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026